Positive outcomes with novel episcleral brachytherapy device for wet AMD

A minimally invasive retrobulbar episcleral brachytherapy device (SMD-I device) (Salutaris Medical Devices) has shown considerable promise in the treatment of a small cohort of exudative AMD patients, according to Kamaljit Balaggan MRCOphth, PhD.
Dr Balaggan reported the feasibility and tolerability of the SMD-I investigational treatment for wet AMD using a single dose of episcleral brachytherapy in conjunction with intraocular anti-VEGF injections.
He noted the strong rationale for using radiation in exudative AMD, taking account of factors such as the radiosensitivity of the proliferating endothelial cells, the reduction in inflammatory and fibrotic processes, and the occlusion of aberrant vessels including vessels with pericyte maturation. Combining radiation treatment and anti-VEGF drugs may reduce the burden of anti-VEGF treatment, increase the proportion of treatment responders and preserve best-corrected visual acuity.
Latest Articles
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Picture This: Photo Contest Winners
ESCRS 2025 Refractive and Cataract Photo Contest winners.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Nutrition and the Eye: A Recipe for Success
A look at the evidence for tasty ways of lowering risks and improving ocular health.
New Award to Encourage Research into Sustainable Practices
Sharing a Vision for the Future
ESCRS leaders update Trieste conference on ESCRS initiatives.
Extending Depth of Satisfaction
The ESCRS Eye Journal Club discuss a new study reviewing the causes and management of dissatisfaction after implantation of an EDOF IOL.
Conventional Versus Laser-Assisted Cataract Surgery
Evidence favours conventional technique in most cases.